Bushra Sikander Dar, MD | |
7840 Vinewood Ln N, Maple Grove, MN 55369-7185 | |
(763) 236-0200 | |
Not Available |
Full Name | Bushra Sikander Dar |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 41 Years |
Location | 7840 Vinewood Ln N, Maple Grove, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639132889 | NPI | - | NPPES |
247223600 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 36786 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairview Southdale Hospital | Edina, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fairview Clinics | 7113830142 | 658 |
News Archive
Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program.
Retrieving organs from brain-dead donors is logistically challenging and time consuming in hospitals. Multiple surgical teams often fly to a donor's hospital but frequently face delays in retrieving organs due to crowded operating-room schedules.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 9 days ago
Entity Name | Fairview Clinics |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program.
Retrieving organs from brain-dead donors is logistically challenging and time consuming in hospitals. Multiple surgical teams often fly to a donor's hospital but frequently face delays in retrieving organs due to crowded operating-room schedules.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Bushra Sikander Dar, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Bushra Sikander Dar, MD 7840 Vinewood Ln N, Maple Grove, MN 55369-7185 Ph: (763) 236-0200 |
News Archive
Elbit Imaging Ltd. that it's subsidiary, InSightec Ltd., the global leader in MR guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that its ExAblate(R) system has been used for the first time for the treatment of prostate cancer patients.
A novel technology developed at Worcester Polytechnic Institute (WPI) to block human infections by taking a lesson from fish has landed a $50,000 grant from the National Science Foundation's Innovation Corps (I-Corps) program.
Retrieving organs from brain-dead donors is logistically challenging and time consuming in hospitals. Multiple surgical teams often fly to a donor's hospital but frequently face delays in retrieving organs due to crowded operating-room schedules.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 9 days ago
Dr. Pamela D Doorenbos, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9825 Hospital Dr, Suite 300, Maple Grove, MN 55369 Phone: 763-494-7500 Fax: 763-494-7501 | |
Keith Johnson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9855 Hospital Dr Ste 102, Maple Grove, MN 55369 Phone: 763-581-5900 Fax: 763-581-5901 | |
Dr. Mark S Hench, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9855 Hospital Dr, Ste 102a, Maple Grove, MN 55369 Phone: 763-581-9220 | |
Mirtha Nesheim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12000 Elm Creek Blvd N, Maple Grove, MN 55369 Phone: 763-420-5822 Fax: 763-420-6387 | |
Ronald B Boeding, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9645 Grove Cir N Ste 200, Maple Grove, MN 55369 Phone: 763-201-8191 Fax: 763-201-8192 | |
Moushumi Meher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Pamela Kolacz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6320 Wedgwood Rd N, Maple Grove, MN 55311 Phone: 763-268-0400 Fax: 763-268-0405 |